Champions Oncology Inc (CSBR) Return on Investment ROI from the first quarter of 2026 to first quarter of 2026 and for the year 2026, average high and low, overall ranking from Jul 31 2026 to Jul 31 2025 - CSIMarket
CSIMarket
 


Champions Oncology Inc   (NASDAQ: CSBR)


Champions Oncology Inc's ROI from its first quarter of 2026 to the first quarter of 2026 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Champions Oncology Inc's ROI in the first quarter of 2026?
Champions Oncology Inc achieved a return on average invested assets (ROI) of 0.22 % in its first quarter of 2026, this is above CSBR's average return on investment of -115.55%.
Champions Oncology Inc invested over the 12 months ending in its first quarter of 2026 $17 million

Despite the deterioration in its net income, company has improved ROI compared to the fourth quarter of 2026.

Within the Healthcare sector 180 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2026 from 3474 to 3611.

Definition and Formula of Return on Investment



Return On Investment (Jul 31 2026)
I. Quarter
(Apr 30 2026)
IV. Quarter
(Jan 31 2026)
III. Quarter
(Oct 31 2025)
II. Quarter
(Jul 31 2025)
I. Quarter
Y / Y Investment Change TTM 43 % 214.21 % - 1375.58 % 1037.04 %
Y / Y Net Income Change TTM -98.67 % - - 19.11 % 122.54 %
Investment (TTM) in Millions 15 7 25 22 24
Return On Investment (TTM) 0.22 % -0.01 % -9.7 % 13.96 % 23.99 %
CSBR's Overall Ranking # 3611 # 3474 # 3167 # 203 # 129
Seq. Investment Change TTM -11.08 % -18.86 % 38.63 % 42.98 % 95.36 %
Seq. Net Income Change TTM - - - -16.8 % -37.84 %
Net Income (TTM) in Millions 0 0 -2 2 3




Return On Investment CSBR's Ranking
Within: No.
Industry # 17
Sector # 181
Overall # 3611

Return On Investment Statistics
High Average Low
127.02 %
-115.55 %
-853.44 %
(Jan 31 2025)   (Oct 31 2017)







Financial Statements
Champions Oncology Inc's I. Quarter Investments $ 15 Millions CSBR's Balance sheet
Champions Oncology Inc's I. Quarter Income $ 0 Millions Quarterly CSBR's Income Statement
CSBR's Income by Division See CSBR's Income by Division


CSBR Annual Return On Investment (Apr 30 2026)
2026
(Apr 30 2025)
2025
(Apr 30 2024)
2024
(Apr 30 2023)
2023
(Apr 30 2022)
2022
Total Investments in Millions 7 4 -2 5 9
Y / Y Investment Growth 86.57 % - - -45.33 % 24.68 %
Net Income in Millions -1 5 -7 -5 1
Y / Y Net Income Growth - - - - 51.38 %
Annual Return On Investment -16.33 % 121.88 % - -102.85 % 5.78 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CSBR's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CSBR's Competitors
Subscribers only: Roi for Champions Oncology Inc's Suppliers
Subscribers only: Return On Investment for CSBR's Customers

Other Ratios
CSBR's Roa CSBR's Inventory Turnover Ratio CSBR's Growth Rates CSBR's Dividend Statistics
CSBR's Profitability Ratios CSBR's Asset Turnover Ratio CSBR's Dividend Growth
CSBR's Roe CSBR's Valuation Ratios CSBR's Financial Strength Ratios CSBR's Dividend Payout Ratio



Companies with similar Return On Investment at Jul 31 2026, within Healthcare Sector ROI
Radnet Inc   0.45 %
Delcath Systems Inc   0.45 %
Champions Oncology Inc   0.18 %
Talkspace Inc   0.16 %
Denali Therapeutics Inc   0.09 %


Date modified: 2026-09-13T23:25:19+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.